Mike Wood MP: speeches

Speeches

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  I beg to move, That this House has considered World Sepsis Awareness Month. As co-chair of the all-party parliamentary group on sepsis, I would like to begin by expressing my gratitude to the Backbench Business Committee for granting time for this debate. To the best of my knowledge, this is the very first debate in the House of Commons Chamber dedicated to sepsis. In the past, this devastating condition has been discussed only in Westminster Hall debates or raised through brief interventions and questions. Having sepsis debated on the Floor of the main Chamber during Sepsis Awareness Month is a major milestone, not only for Parliament but for the clinicians, charities and bereaved families across the country who have campaigned tirelessly to bring this condition out of the shadows. I would also like to thank the co-sponsors of this debate: the hon. Member for Ashfield (Lee Anderson), who cannot be here this afternoon but who led an important Westminster Hall debate on this subject two years ago, and the hon. Member for Dartford (Jim Dickson), vice-chair of the APPG. Sepsis strikes indiscriminately, ruthlessly and with terrifying speed, without regard for background, class or, indeed, political allegiance. It is vital that we all stand united in our determination to tackle this deadly condition. It is a challenge that completely transcends party politics. On Sunday, communities across the world marked World Sepsis Day. The international theme for this year could not be more apt: “Invest in Sepsis—Save Lives.” The World Health Organisation recognises sepsis as one of the leading causes of death and disability globally, estimating that sepsis-related illnesses account for one in every five deaths worldwide. In the United Kingdom, NHS England has made it clear that sepsis claims more lives each year than lung cancer and represents the second biggest killer in our hospitals after cardiovascular disease. Every single year, an estimated 245,000 people in the UK develop sepsis and, tragically, more than 48,000 lose their lives. That is a higher annual death toll than bowel, breast and prostate cancers combined. Behind every one of those figures is a family left grieving and asking the same agonising question: what if? What if the symptoms had been recognised an hour earlier? What if antibiotics had been administered sooner? What if someone had simply asked, “Could it be sepsis?”? Madam Deputy Speaker, as you know, I do not approach this debate purely as a parliamentarian dispassionately analysing policy responses to one of the leading causes of avoidable death. I stand in this Chamber today because almost a decade ago, by the grace of God and the extraordinary skill and care of NHS staff, my life was saved. In January 2017, I was a relatively fit and active 40-year-old Member of Parliament. I had developed what I assumed was merely a winter infection. Like many people would, I assumed that I could push through it, take some paracetamol and carry on working. I travelled out to Strasbourg to take part in the Parliamentary Assembly of the Council of Europe on the Sunday evening, but within days my condition collapsed. An ordinary throat infection triggered a catastrophic immune response. My body, in attempting to fight the infection, began attacking its own tissues and organs. By Thursday, after seeing a French GP, I flew back to Britain. On Friday, I attended the official launch of the local enterprise zone that I had campaigned hard for in my constituency, but as soon as I arrived there I was so ill that I had to rest in the back room. On Saturday morning, I got out of bed, started putting my suit on over my pyjamas and told my wife Laura that I had to come down to Westminster to vote. Like many in politics, my behaviour can at times appear to some people to be a little idiosyncratic; fortunately, Laura realised that, even for a Member of Parliament, that was not entirely normal behaviour. Laura rushed me to Russells Hall hospital in Dudley, where my blood pressure plummeted into septic shock and my organs began shutting down. My life was hanging by a thread. The medical team had to place me in a medically induced coma. Doctors told my family that my chances of pulling through were no better than one in 10. For 11 days, I lay in intensive care on life support—or, as my family sometimes remind me, I slept through the difficult bits. When I did finally wake up, my muscles had wasted away—I could barely lift my arms, let alone stand or walk—but it could easily have been so much worse. What if Laura had left me to get some rest that Saturday morning while she took our daughter to her dance class? Above all, what if the nurse who examined me at the accident and emergency department had not had the insight to check whether the symptoms, which could easily have been mistaken for other illnesses such as flu or meningitis, might be sepsis? I owe a debt of gratitude to the doctors, intensive care nurses and other staff at Russells Hall hospital that I can never repay, but as long as I have the honour of serving in this House, I will use my voice to fight for sepsis patients and their families. There is a common misconception that sepsis is primarily the result of hospital-acquired infection, but the evidence demonstrates the exact opposite. A major 2024 population study led by Professor van Staa, analysing linked primary care and hospital data in England, showed that the vast majority of sepsis cases are community acquired, developing in homes, workplaces and local communities long before a patient reaches an acute hospital bed. That research also uncovered deep health inequalities in sepsis risk. The risk of developing sepsis is significantly heightened by socioeconomic deprivation, by frailty, by being housebound and by chronic conditions such as cancer, diabetes and learning disabilities. Exposure to antibiotics in the previous two months was also identified as a strong risk factor. While ethnicity was not an independent biological factor, black and Asian individuals suffer from a higher prevalence of predisposing conditions including diabetes, chronic liver disease and severe anaemia, which puts them at a greater risk, so tackling sepsis is not merely a technical, clinical issue but a fundamental challenge of health inequality and community prevention. One of the most critical clinical lessons learned in recent years is the direct link between viral infections and sepsis. For decades, the public and the medical community viewed sepsis almost exclusively as a bacterial complication, but the covid-19 pandemic demonstrated that viral infections can trigger the exact same catastrophic septic response. The overwhelming cytokine storms, microvascular clotting and rapid progression to acute respiratory distress syndrome and multi-organ failure seen in covid intensive care units are classic manifestations of viral sepsis. It is thought by many experts in the field that the vast majority of covid deaths were a direct result of septic reactions. Sepsis is not defined by the pathogen; it is defined by the body’s life-threatening immune reaction to any severe infection, whether bacterial, viral or fungal. That reality extends directly into long-term recovery: millions who had covid-19 are still living with long covid. Sepsis survivors have known that reality for generations under the name of post-sepsis syndrome. In my case, it is little more than some nerve damage and tiredness, even a decade later, but for many the symptoms are more severe. Up to 50% of sepsis survivors suffer prolonged physical, cognitive and psychological impairments from debilitating fatigue and cognitive brain fog to severe muscle weakness and post-traumatic stress disorder. The clinical insights gained from viral sepsis during the pandemic must now be used to build integrated recovery pathways for all sepsis survivors. To curb preventable deaths, a health system must act decisively in several areas; in the interests of time, I will go through just four. First, the system must ensure consistent rapid recognition. Time is the single most decisive factor in sepsis survival. Clinical research shows that administering appropriate antibiotics within the first hour of a patient presenting to an emergency department with sepsis reduces the risk of death by a full one third compared with delayed treatment. Secondly, the system must ensure that where sepsis is suspected, appropriate clinical escalation pathways are in place. Where sepsis is suspected, early warning systems such as the national early warning score 2, or NEWS2, have saved countless lives, and the ongoing roll-out of Martha’s rule across NHS trusts, which has already saved thousands of lives, is vital in ensuring that patients and loved ones can trigger an immediate independent critical review when they sense deterioration. Thirdly, we must take advantage of innovation in rapid diagnostics. We know that administering broad-spectrum antibiotics within the golden hour that I spoke of massively increases survival rates, but clinicians often face the dilemma of judging whether that is compatible with responsible antimicrobial stewardship. Deploying rapid molecular diagnostics, bedside biomarker technologies and wearable continuous physiological monitors can remove that guesswork, and provide targeted care before septic shock takes hold and it can be too late. Fourthly, although Britain has in many ways led the way in developing and enhancing sepsis care and treatment, we must be open to learning from established international models and practices. Sweden utilises standard sepsis alerts to prioritise patients at triage, and implements mandatory post-discharge telephone follow-ups. France, where I was when I was taken ill, has since introduced an integrated national sepsis plan spanning pre-hospital recognition, emergency pathways and structured rehabilitation to help patients return to employment. Australia established a national sepsis clinical care standard built around seven quality statements, ensuring end-to-end consistency from triage through to survivorship. The publication in July of the sepsis modern service framework by NHS England and the Department of Health and Social Care is an important step towards doing that and learning the lessons from around the world; I warmly welcome it. The framework is one of the first to be published under the 10-year health plan. Its headline goal, “to reduce deaths, severe complications and long-term harm from sepsis…by at least 25% by 2035” is a target that every member of this House can endorse.

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  The hon. Lady makes a really important point. We know how these conditions can come round in a cycle. In order to break that cycle, we will need multiple years of vaccination. The modern service framework contains a number of vital commitments, but I particularly welcome: action 4 on improving the audit and feedback of sepsis-related clinical data across trusts; action 5 on updating training for NHS staff, social care workers and unpaid carers; action 9 on optimising care pathways and expanding access to rapid diagnostics and specialist advice; action 11 on standardising digital specifications for early warning systems such as NEWS2; and action 12 on reviewing and addressing capacity gaps in critical and enhanced care. A strategy on paper will not be enough to save a deteriorating patient on a cold winter weekend in an overcrowded emergency department. In the other place, my noble friend and our former colleague Lord Mackinlay of Richborough, who has spoken with enormous courage about his own life-altering encounter with sepsis, has repeatedly tabled written questions seeking clarity on how this framework will be delivered. Regrettably, the answers provided by Ministers in the Lords to date have been rather generic and vague, and lacking in operational detail. We cannot accept boilerplate responses on a condition that kills 48,000 people each year, so I have two direct questions that I hope the Minister will answer in her response to today’s debate. First, what are the specific milestone-driven timelines for the delivery of each of the actions set out in the modern service framework, and when will trusts and integrated care boards be expected to have these standardised pathways fully operational? Secondly, can the Minister assure the House that the Department of Health and Social Care is prepared to commit the dedicated investment required to make this framework work? When we call for investment, we must be clear that funding sepsis care is not an open-ended cost. It is one of the most cost-effective investments that the Department can make. Sepsis currently places an enormous financial burden on the national health service and the wider economy. Too often, cases of missed or delayed diagnosis and treatment result in weeks of high-cost intensive care unit admissions, in emergency readmissions due to incomplete recovery, in complex surgical interventions including amputations requiring lifelong prosthetic and social care support, or in the permanent loss of working-age adults from the workforce. Investing in rapid bedside diagnostics, digital early warning systems, specialist outreach teams and structured post-sepsis rehabilitation can dramatically reduce the lengths of stay in intensive care, lower readmission rates and keep people in work. Early intervention is not only clinically imperative; it is economically sound, and the theme “Invest in sepsis—save lives” is a call for smart preventive healthcare investment.

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  Absolutely. Of course, some infections are almost unavoidable, but where infections such as UTIs can clearly be reduced with the right care and precautions, we must do everything we can to reduce those risks. Every Member in this Chamber has constituents whose lives have been permanently transformed by sepsis. Some Members have been directly impacted or have watched as close family and friends have encountered sepsis. We know the speed with which it strikes, but we also know that with early detection, immediate treatment and high quality critical care, thousands of lives can be saved. We have the clinical evidence and we have the modern service framework. What we now need is clear delivery timelines, rigorous parliamentary accountability and the necessary financial backing to make this ambition a reality. If the Minister can deliver this and provide the resources and tools that the NHS needs to implement it, the modern service framework truly can be a turning point in the fight against this silent killer and the battle to save thousands of lives.

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  I thank all hon. Members who contributed to the debate. The hon. Member for Dartford (Jim Dickson) spoke movingly about his constituent John. I was particularly pleased to hear how well he is now doing since recovering and about the support his family received from the community—in particular the work that Dartford working men’s club is doing in the community. If we are to really increase awareness so that people understand both the science and the risks of sepsis, it cannot be left to the NHS alone. It really does need to be a full community effort, so it is great to hear that the working men’s club is taking a lead. He also, rightly, spoke about the importance of data. Part of the problem is inconsistency in reporting sepsis cases. That makes it so difficult to have a meaningful figure for the number of cases, deaths and serious disabilities as a result of sepsis. We really need more consistency in the way that is coded, as well as a guide to best practice. I join the Minister in offering my condolences to the hon. Member for Carlisle (Ms Minns) on the sad loss of her mother; it must have been an unbearably difficult time. She also spoke about her constituent Kelly, and gave us the very important message that different people experience sepsis very differently, both in terms of outcomes and the lasting impact, as well as the nature of their sepsis. We heard important interventions from the hon. Members for Mid Dorset and North Poole (Vikki Slade), for Stoke-on-Trent South (Dr Gardner) and for Wolverhampton North East (Sureena Brackenridge). The Liberal Democrat spokesperson, the hon. Member for Winchester (Dr Chambers), referred to the force of nature that is Ron Daniels, who has done so much to push sepsis up the public agenda, and to change the way that the NHS understands and responds to sepsis. We all owe him a huge debt. The shadow Minister, my hon. Friend the Member for Sleaford and North Hykeham (Dr Johnson), spoke about how notoriously difficult sepsis is to diagnose, and about the issues around prenatal strep and the additional work that needs to be done in both understanding and responding to the sepsis that arises. I thank the Minister for the kind words she offered to me, and for the spirit of her response, particularly around the implementation plan and funding. She rightly referred to Martha’s rule, and the importance of ensuring that families, who know their children better than anyone else, are allowed to insist on an independent second opinion if they feel that there has been a deterioration in condition. I will briefly thank the many campaigners who have worked so hard on this issue—often because, sadly, they or a member of their family has been affected. They are too numerous to name, but I will mention the incredible work done by Harry Redknapp, who works tirelessly, and often without an awful lot of publicity and credit, to raise awareness of sepsis following his wife Sandra’s illness—I think he was in the jungle on “I’m a Celebrity...Get Me Out of Here!” when she was taken ill. Harry does so much incredible work voluntarily. Researchers and charities do incredible work, including Sepsis Research, and particularly the UK Sepsis Trust—both Ron Daniels and Sarah Hamilton-Fairley have helped to keep the issue rising to the level of importance it deserves. I thank all Members for the valuable contributions they have made today, and I look forward to holding the Minister to account as she delivers on the modern service framework. Question put and agreed to. Resolved, That this House has considered World Sepsis Awareness Month.

• 6 Jul 2026 · Payment Scheme · Hansard source

  More

  I would like to start by thanking the Paymaster General for bringing forward these important regulations and also to say thank you to the former Minister for Public Health, the hon. Member for West Lancashire (Ashley Dalton), for her valuable work when she was in office. This debate takes place in the shadow of one of the gravest injustices in modern British history. The infected blood scandal caused unimaginable harm, with lives lost, families devastated, careers destroyed, potential never realised, children robbed of parents and many victims forced to fight for decades just for recognition and to be heard. Compensation is not a gift from the state; it is a duty owed to those who were failed by the state. That duty must be delivered with urgency, compassion and fairness. The regulations make a number of amendments to the Infected Blood Compensation Scheme Regulations 2025. Many of the changes appear to address concerns raised by victims, families and campaigners about the structure and adequacy of the scheme and, obviously, those contained in the additional report. His Majesty’s Opposition welcome the Government bringing forward these amendments to address the lessons learned from the early stages of the compensation scheme, to fill in some of the gaps and to implement the recommendations of Sir Brian Langstaff’s additional report. However, the existence of this instrument also underlines the importance of getting the scheme right. Victims and their families have already waited far too long. They must not be required to navigate repeated technical changes, uncertainty or delays before receiving the compensation and recognition they deserve. The regulations also amend the method for calculating past and future amounts for certain awards, including financial loss awards. I would be grateful if the Minister sets out clearly how the Government will ensure that those changes are properly communicated to victims and to families so that people understand how their entitlement will be calculated and whether they may be better off as a result. The changes are sensible but, by necessity, regulations can appear rather daunting. My degree was in economics and law, and I am reasonably comfortable with legal texts and with algebra, but at first glance we can wonder what language some of it is written in, so it is obviously important that they are communicated in a way that can be properly understood. His Majesty’s Opposition also welcome the changes to the autonomy award for those infected as children. The fact that some people were infected at such a young age, with consequences that shaped their entire childhood and adult life, must be properly reflected in the scheme. This is not simply a question of medical impact; it is about lost childhoods, lost opportunities and the lifelong trauma experienced by those who infected when they were at their most vulnerable. There are also changes in relation to unethical research practices, which we have discussed many times in the Chamber. We greatly welcome the increase in the relevant award amounts and the extension in provision to those who received treatment for bleeding disorders before 1986. Given the seriousness of the issue, will the Minister confirm how the Government will identify those who fall into that category and what evidence he expects they will have to provide so that the process does not become another source of distress for victims and their families? We also note the creation of a new “severe health condition” category for qualifying chronic hepatitis-associated conditions based on support scheme categories. Again, we would welcome clarity from the Minister on how he expects that to work in practice and in particular how the Government will ensure consistency across England, Scotland, Wales and Northern Ireland. The amendments to affected injury awards are also significant. Families were not bystanders to this scandal; partners, parents, children and siblings lived with the consequences every day. Many provided care, endured bereavement, suffered stigma and experienced profound emotional and financial harm. The scheme must continue to recognise that the damage caused by this scandal extended far beyond those directly infected. Therefore, while these technical changes matter greatly, the central question remains delivery. Victims and families need to know when they will receive compensation, including as a result of the new regulations. They need to know how quickly claims will be processed, what support will be available to them to navigate the scheme, and how the Government will ensure that truly no one is left behind. I therefore ask the Minister to address the following points. First, what is his intended timetable for payments under the regulations, and how many people do the Government expect to receive compensation in the coming months? Secondly, how confident is he that that the Infected Blood Compensation Authority has the staffing, expertise and resources it needs to process claims under the regulations quickly and sensitively?